Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 in Healthy Subjects
Clinical trial NCT03830125 · COMPLETED
Trial details
- NCT number
- NCT03830125
- Sponsor
- Bridge Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-13
- Primary completion
- 2019-11-24
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.